GLP-1 Drugs Linked to 37% to 68% Higher Hair Loss Risk in BMJ Study

Adults with type 2 diabetes on GLP-1 agonists like Ozempic and Mounjaro had a 37% to 68% higher alopecia rate than those on two other diabetes drug classes, a Penn Medicine study in The BMJ found.